GW Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. GW Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4039% to $527,205,000. The net income raised on -$58,128,000 and profit margin reached -11%. Total operating expenses were $541,439,000.
Profit Margin
| 2010 | 48.45M | 7.33M | 15.13% |
|---|---|---|---|
| 2011 | 46.20M | 4.28M | 9.28% |
| 2012 | 53.45M | 4.01M | 7.52% |
| 2013 | 44.12M | -7.35M | -16.67% |
| 2014 | 48.79M | -23.80M | -48.79% |
| 2015 | 43.24M | -67.53M | -156.14% |
| 2016 | 13.44M | -82.94M | -617.13% |
| 2017 | 11.03M | -176.41M | -1598.54% |
| 2018 | 12.73M | -295.16M | -2317.4% |
| 2020 | 527.20M | -58.12M | -11.03% |
GWPH Income Statement (2010 – 2020)
| 2020 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 527.20M | 12.73M | 11.03M | 13.44M | 43.24M | 48.79M | 44.12M | 53.45M | 46.20M | 48.45M |
Cost of revenue | 37.53M | 5.98M | 4.74M | 3.54M | 3.96M | 3.34M | 2.06M | 1.35M | 2.10M | 1.18M |
Gross profit | 489.67M | 6.75M | 6.29M | 9.89M | 39.28M | 45.44M | 42.06M | 52.10M | 44.10M | 47.26M |
Operating exp. | ||||||||||
Research and development | 205.39M | 153.73M | 149.01M | 130.05M | 116.36M | 70.60M | 52.85M | 44.51M | 34.81M | 34.47M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 541.43M | 295.55M | 204.87M | 156.03M | 135.40M | 82.52M | 58.98M | 50.41M | 40.71M | 40.16M |
Operating income | -51.76M | -288.80M | -198.58M | -146.14M | -96.12M | -37.07M | -16.92M | 1.68M | 3.38M | 7.10M |
Other income (expenses), net | -3.28M | -2.56M | -5.59M | 33.85M | 9.65M | 5.28M | 184.29K | 321.18K | -555.18K | -170.59K |
Income before tax | -55.04M | -291.37M | -204.17M | -112.28M | -86.47M | -31.78M | -16.74M | 2.00M | 3.94M | 7.27M |
Income tax expense | 3.08M | 3.79M | -27.75M | -29.33M | -18.93M | -7.97M | -9.38M | -2.01M | -344.65K | -58.44K |
Net income | -58.12M | -295.16M | -176.41M | -82.94M | -67.53M | -23.80M | -7.35M | 4.01M | 4.28M | 7.33M |
Earnings per share | ||||||||||
Basic EPS | -1.85 | -10.61 | -6.98 | -3.67 | -3.29 | -1.36 | -0.58 | 0.36 | 0.39 | 0.68 |
Diluted EPS | -1.85 | -10.61 | -6.98 | -3.67 | -3.29 | -1.36 | -0.58 | 0.34 | 0.37 | 0.64 |
| Data source |